西斯普拉丁诱导的肌肉损耗和缩:分子机制和潜在的治疗干预措施
Ko-Chieh Huang1, Yi-Fen Chiang1, Mohamed Ali2,3
1School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan.
Journal of cachexia, sarcopenia and muscle
|May 9, 2025
概括
西斯普拉丁化疗会导致肌肉缩,影响癌症患者. 这篇评论探讨了分子疗法和天然化合物,如素,以对抗这种副作用,改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 西斯普拉丁是治疗各种癌症的重要化疗剂.
- 西斯普拉丁诱导肌肉缩,导致身体力量和生活质量下降.
- 肌肉消耗来自西斯丁,涉及增加的蛋白质分解,减少的蛋白质合成和炎症.
研究的目的:
- 系统地审查基于分子的疗法和植物衍生化合物,以预防西斯胺诱导的肌肉缩.
- 提供这些干预措施体内和体外疗效的概述.
- 确定潜在的治疗点,以减轻化疗引起的肌肉衰竭.
主要方法:
- 关于分子疗法和天然化合物的研究的系统文献综述.
- 在体内和体外对抗西斯胺诱导肌肉缩的疗效数据的分析.
- 探索其作用机制,包括合成代谢刺激和抗炎作用.
主要成果:
- 分子疗法 (如格林,丸激素) 促进肌肉生长并减少降解.
- 天然化合物 (如素,纳灵宁) 降低炎症和氧化应激.
- 这两种方法都在临床前模型中显示出预防肌肉缩的前景.
结论:
- 基于分子和天然化合物的疗法提供了有前途的策略来抵消西斯普拉丁诱导的肌肉缩.
- 向合成途径和减少炎症/氧化应激是关键机制.
- 需要进一步的研究和临床转化,以改善癌症患者在化疗期间的治疗结果.
相关概念视频
01:21Satellite Stem Cells and Muscular Dystrophy
1.7K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.7K
01:21Skeletal Muscle Relaxants: Adverse Effects
1.2K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
1.2K